Is a lower dose of cetrorelix acetate effective for prevention of LH surge during controlled ovarian hyperstimulation?

Journal of Assisted Reproduction and Genetics

Volumn 23, Issue 6, 2006, Pages 289-292

  Chen, Heng Ju ^a,b   Lin, Yu Hung ^a,b   Hsieh, Bih Chwen ^a,b   Seow, Kok Min ^a   Hwang, Jiann Loung ^a,b,c   Tzeng, Chii Ruey ^c  

^a SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Cetrorelix; GnRH antagonist; In vitro fertilization; LH surge

Indexed keywords

CETRORELIX; CHORIONIC GONADOTROPIN; ESTRADIOL; LUTEINIZING HORMONE; RECOMBINANT FOLLITROPIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; EMBRYO TRANSFER; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; FETUS DEATH; FOLLICULAR PHASE; HUMAN; LUTEINIZING HORMONE BLOOD LEVEL; MENSTRUAL CYCLE; OVARY HYPERSTIMULATION; PREGNANCY; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ADULT; DOSE-RESPONSE RELATIONSHIP, DRUG; EMBRYO TRANSFER; ESTRADIOL; FEMALE; FERTILITY AGENTS, FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMANS; LUTEINIZING HORMONE; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE;

EID: 33748780621     PISSN: 10580468     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10815-006-9054-0     Document Type: Article

References (17)

1. Diedrich K, Diedrich C, Santos E, Zoll C, al-Hasani S, Reissmann T, Krebs D, Klingmuller D: Suppression of the endogenous luteinizing hormone surge by the gonadotropin-releasing hormone antagonist Cetrorelix during ovarian stimulation. Hum Reprod 1994;9:788-91.
2. Albano C, Smitz J, Camus M, Riethmuller-Winzen H, Van Steirteghem A, Devroey P: Comparison of different doses of gonadotropin-releasing hormone antagonist Cetrorelix during controlled ovarian hyperstimulation. Fertil Steril 1997;67:917-22.
3. Felberbaum RE, Albano C, Ludwig M, Riethmuller-Winzen H, Grigat M, Devroey P, Diedrich K: Ovarian stimulation for assisted reproduction with HMG and concomitant midcycle administration of the GnRH antagonist cetrorelix according to the multiple dose protocol: a prospective uncontrolled phase III study. Hum Reprod 2000;15:1015-20.
4. Al-Inany H, Aboulghar M: GnRH antagonist in assisted reproduction: a Cochrane review. Hum Reprod 2002;17:874-85.
5. Hernandez ER: Embryo implantation and GnRH antagonists: embryo implantation: the Rubicon for GnRH antagonists. Hum Reprod 2000;15:1211-16.
6. Ganirelix Dose-Finding Study Group: A double-blind, randomized, dose-finding study to assess the efficacy of the GnRH antagonist Ganirelix (Org 37462) to prevent premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation with recombinant follicle stimulating hormone. Hum Reprod 1998;13:3023-31.
7. Felberbaum R, Reissmann T, Kupker W, Al-Hasani S, Bauer O, Schill T, Zoll C, Diedrich C, Diedrich K: Hormone profiles under ovarian stimulation with human menopausal gonadotropin (hMG) and concomitant administration of the gonadotropin releasing hormone (GnRH)-antagonist Cetrorelix at different dosages. J Assist Reprod Genet 1996;13:216-22.
8. Raga F, Casan EM, Kruessel J, Wen Y, Bonilla-Musoles F, Polan ML: The role of gonadotropin-releasing hormone in murine preimplantation embryonic development. Endocrinology 1999;140:3705-12.
9. Seelig AS, Al-Hasani S, Katalinic A, Schopper B, Sturm R, Diedrich K, Ludwig M: Comparison of cryopreservation outcome with gonadotropin-releasing hormone agonists or antagonists in the collecting cycle. Fertil Steril 2002;77:472-75.
10. Kol S, Lightman A, Hillensjo T, Devroey P, Fauser B, Tarlatzis B, Mannaerts B, Itskovitz-Eldor J: High doses of gonadotrophin-releasing hormone antagonist in in-vitro fertilization cycles do not adversely affect the outcome of subsequent freeze-thaw cycles. Hum Reprod 1999;14:2242-44.
11. Dong KW, Marcelin K, Hsu MI, Chiang CM, Hoffman G, Roberts JL: Expression of gonadotropin-releasing hormone (GnRH) gene in human uterine endometrial tissue. Mol Hum Reprod 1998;4:893-98.
12. Engel JB, Riethmuller-Winzen H, Diedrich K: Extrapituitary effects of GnRH antagonists in assisted reproduction: a review. Reprod Biomed Online 2005;10:230-34.
13. Albano C, Felberbaum RE, Smitz J, Riethmuller-Winzen H, Engel J, Diedrich K, Devroey P: Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. European Cetrorelix Study Group. Hum Reprod 2000;15:526-31.
14. Al-Inany H, Aboulghar MA, Mansour RT, Serour GI: Optimizing GnRH antagonist administration: meta-analysis of fixed versus flexible protocol. Reprod Biomed online 2005;10:567-70.
15. Hwang JL, Huang LW, Hsieh BC, Tsai YL, Huang SC, Chen CY, Hsieh ML, Chen PH, Lin YH: Ovarian stimulation by clomiphene citrate and hMG in combination with cetrorelix acetate for ICSI cycles. Hum Reprod 2003;18:45-9.
16. Hardy RI, Tummon IS, Hosseinzadeh M: Luteinizing hormone (LH) surge on ganirelix (Antagon) is related to body mass index (BMI). Fertil Steril 2001;73:178-79.
17. Engel JB, Ludwig M, Junge K, Howles CM, Diedrich K: No influence of body weight on pregnancy rate in patients treated with cetrorelix according to the single- and multiple-dose protocols. Reprod Biomed Online 2003;6:482-87.